Genetic Carrier Screening Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB510251077

Publication Date:

October 5, 2024

Pages:

115

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global market for Genetic Carrier Screening Service was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Genetic Carrier Screening Service was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Genetic Carrier Screening Service was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Genetic Carrier Screening Service was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Genetic Carrier Screening Service include Clinical Labs, Eurofins Scientific, Fulgent Genetics, Gene by Gene, Illumina, Invitae, MedGenome Labs, My Baby Company and Myriad Genetics, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Genetic Carrier Screening Service, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Genetic Carrier Screening Service by region & country, by Type, and by Application.
The Genetic Carrier Screening Service market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genetic Carrier Screening Service.
Market Segmentation
By Company
Clinical Labs
Eurofins Scientific
Fulgent Genetics
Gene by Gene
Illumina
Invitae
MedGenome Labs
My Baby Company
Myriad Genetics
Natera
NxGen MDx, LLC
OPKO Health
Thermo Fisher Scientific
Sonic Genetics
Segment by Type:
Expanded Carrier Screening Service
Targeted Disease Carrier Screening Service
Segment by Application
Pregnant Woman
Couple
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Genetic Carrier Screening Service manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Genetic Carrier Screening Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Genetic Carrier Screening Service in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Genetic Carrier Screening Service Product Introduction
1.2 Global Genetic Carrier Screening Service Market Size Forecast
1.3 Genetic Carrier Screening Service Market Trends & Drivers
1.3.1 Genetic Carrier Screening Service Industry Trends
1.3.2 Genetic Carrier Screening Service Market Drivers & Opportunity
1.3.3 Genetic Carrier Screening Service Market Challenges
1.3.4 Genetic Carrier Screening Service Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Genetic Carrier Screening Service Players Revenue Ranking (2023)
2.2 Global Genetic Carrier Screening Service Revenue by Company (2019-2024)
2.3 Key Companies Genetic Carrier Screening Service Manufacturing Base Distribution and Headquarters
2.4 Key Companies Genetic Carrier Screening Service Product Offered
2.5 Key Companies Time to Begin Mass Production of Genetic Carrier Screening Service
2.6 Genetic Carrier Screening Service Market Competitive Analysis
2.6.1 Genetic Carrier Screening Service Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Genetic Carrier Screening Service Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genetic Carrier Screening Service as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Expanded Carrier Screening Service
3.1.2 Targeted Disease Carrier Screening Service
3.2 Global Genetic Carrier Screening Service Sales Value by Type
3.2.1 Global Genetic Carrier Screening Service Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Genetic Carrier Screening Service Sales Value, by Type (2019-2030)
3.2.3 Global Genetic Carrier Screening Service Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pregnant Woman
4.1.2 Couple
4.2 Global Genetic Carrier Screening Service Sales Value by Application
4.2.1 Global Genetic Carrier Screening Service Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Genetic Carrier Screening Service Sales Value, by Application (2019-2030)
4.2.3 Global Genetic Carrier Screening Service Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Genetic Carrier Screening Service Sales Value by Region
5.1.1 Global Genetic Carrier Screening Service Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Genetic Carrier Screening Service Sales Value by Region (2019-2024)
5.1.3 Global Genetic Carrier Screening Service Sales Value by Region (2025-2030)
5.1.4 Global Genetic Carrier Screening Service Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Genetic Carrier Screening Service Sales Value, 2019-2030
5.2.2 North America Genetic Carrier Screening Service Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Genetic Carrier Screening Service Sales Value, 2019-2030
5.3.2 Europe Genetic Carrier Screening Service Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Genetic Carrier Screening Service Sales Value, 2019-2030
5.4.2 Asia Pacific Genetic Carrier Screening Service Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Genetic Carrier Screening Service Sales Value, 2019-2030
5.5.2 South America Genetic Carrier Screening Service Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Genetic Carrier Screening Service Sales Value, 2019-2030
5.6.2 Middle East & Africa Genetic Carrier Screening Service Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Genetic Carrier Screening Service Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Genetic Carrier Screening Service Sales Value
6.3 United States
6.3.1 United States Genetic Carrier Screening Service Sales Value, 2019-2030
6.3.2 United States Genetic Carrier Screening Service Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Genetic Carrier Screening Service Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Genetic Carrier Screening Service Sales Value, 2019-2030
6.4.2 Europe Genetic Carrier Screening Service Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Genetic Carrier Screening Service Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Genetic Carrier Screening Service Sales Value, 2019-2030
6.5.2 China Genetic Carrier Screening Service Sales Value by Type (%), 2023 VS 2030
6.5.3 China Genetic Carrier Screening Service Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Genetic Carrier Screening Service Sales Value, 2019-2030
6.6.2 Japan Genetic Carrier Screening Service Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Genetic Carrier Screening Service Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Genetic Carrier Screening Service Sales Value, 2019-2030
6.7.2 South Korea Genetic Carrier Screening Service Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Genetic Carrier Screening Service Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Genetic Carrier Screening Service Sales Value, 2019-2030
6.8.2 Southeast Asia Genetic Carrier Screening Service Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Genetic Carrier Screening Service Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Genetic Carrier Screening Service Sales Value, 2019-2030
6.9.2 India Genetic Carrier Screening Service Sales Value by Type (%), 2023 VS 2030
6.9.3 India Genetic Carrier Screening Service Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Clinical Labs
7.1.1 Clinical Labs Profile
7.1.2 Clinical Labs Main Business
7.1.3 Clinical Labs Genetic Carrier Screening Service Products, Services and Solutions
7.1.4 Clinical Labs Genetic Carrier Screening Service Revenue (US$ Million) & (2019-2024)
7.1.5 Clinical Labs Recent Developments
7.2 Eurofins Scientific
7.2.1 Eurofins Scientific Profile
7.2.2 Eurofins Scientific Main Business
7.2.3 Eurofins Scientific Genetic Carrier Screening Service Products, Services and Solutions
7.2.4 Eurofins Scientific Genetic Carrier Screening Service Revenue (US$ Million) & (2019-2024)
7.2.5 Eurofins Scientific Recent Developments
7.3 Fulgent Genetics
7.3.1 Fulgent Genetics Profile
7.3.2 Fulgent Genetics Main Business
7.3.3 Fulgent Genetics Genetic Carrier Screening Service Products, Services and Solutions
7.3.4 Fulgent Genetics Genetic Carrier Screening Service Revenue (US$ Million) & (2019-2024)
7.3.5 Gene by Gene Recent Developments
7.4 Gene by Gene
7.4.1 Gene by Gene Profile
7.4.2 Gene by Gene Main Business
7.4.3 Gene by Gene Genetic Carrier Screening Service Products, Services and Solutions
7.4.4 Gene by Gene Genetic Carrier Screening Service Revenue (US$ Million) & (2019-2024)
7.4.5 Gene by Gene Recent Developments
7.5 Illumina
7.5.1 Illumina Profile
7.5.2 Illumina Main Business
7.5.3 Illumina Genetic Carrier Screening Service Products, Services and Solutions
7.5.4 Illumina Genetic Carrier Screening Service Revenue (US$ Million) & (2019-2024)
7.5.5 Illumina Recent Developments
7.6 Invitae
7.6.1 Invitae Profile
7.6.2 Invitae Main Business
7.6.3 Invitae Genetic Carrier Screening Service Products, Services and Solutions
7.6.4 Invitae Genetic Carrier Screening Service Revenue (US$ Million) & (2019-2024)
7.6.5 Invitae Recent Developments
7.7 MedGenome Labs
7.7.1 MedGenome Labs Profile
7.7.2 MedGenome Labs Main Business
7.7.3 MedGenome Labs Genetic Carrier Screening Service Products, Services and Solutions
7.7.4 MedGenome Labs Genetic Carrier Screening Service Revenue (US$ Million) & (2019-2024)
7.7.5 MedGenome Labs Recent Developments
7.8 My Baby Company
7.8.1 My Baby Company Profile
7.8.2 My Baby Company Main Business
7.8.3 My Baby Company Genetic Carrier Screening Service Products, Services and Solutions
7.8.4 My Baby Company Genetic Carrier Screening Service Revenue (US$ Million) & (2019-2024)
7.8.5 My Baby Company Recent Developments
7.9 Myriad Genetics
7.9.1 Myriad Genetics Profile
7.9.2 Myriad Genetics Main Business
7.9.3 Myriad Genetics Genetic Carrier Screening Service Products, Services and Solutions
7.9.4 Myriad Genetics Genetic Carrier Screening Service Revenue (US$ Million) & (2019-2024)
7.9.5 Myriad Genetics Recent Developments
7.10 Natera
7.10.1 Natera Profile
7.10.2 Natera Main Business
7.10.3 Natera Genetic Carrier Screening Service Products, Services and Solutions
7.10.4 Natera Genetic Carrier Screening Service Revenue (US$ Million) & (2019-2024)
7.10.5 Natera Recent Developments
7.11 NxGen MDx, LLC
7.11.1 NxGen MDx, LLC Profile
7.11.2 NxGen MDx, LLC Main Business
7.11.3 NxGen MDx, LLC Genetic Carrier Screening Service Products, Services and Solutions
7.11.4 NxGen MDx, LLC Genetic Carrier Screening Service Revenue (US$ Million) & (2019-2024)
7.11.5 NxGen MDx, LLC Recent Developments
7.12 OPKO Health
7.12.1 OPKO Health Profile
7.12.2 OPKO Health Main Business
7.12.3 OPKO Health Genetic Carrier Screening Service Products, Services and Solutions
7.12.4 OPKO Health Genetic Carrier Screening Service Revenue (US$ Million) & (2019-2024)
7.12.5 OPKO Health Recent Developments
7.13 Thermo Fisher Scientific
7.13.1 Thermo Fisher Scientific Profile
7.13.2 Thermo Fisher Scientific Main Business
7.13.3 Thermo Fisher Scientific Genetic Carrier Screening Service Products, Services and Solutions
7.13.4 Thermo Fisher Scientific Genetic Carrier Screening Service Revenue (US$ Million) & (2019-2024)
7.13.5 Thermo Fisher Scientific Recent Developments
7.14 Sonic Genetics
7.14.1 Sonic Genetics Profile
7.14.2 Sonic Genetics Main Business
7.14.3 Sonic Genetics Genetic Carrier Screening Service Products, Services and Solutions
7.14.4 Sonic Genetics Genetic Carrier Screening Service Revenue (US$ Million) & (2019-2024)
7.14.5 Sonic Genetics Recent Developments
8 Industry Chain Analysis
8.1 Genetic Carrier Screening Service Industrial Chain
8.2 Genetic Carrier Screening Service Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Genetic Carrier Screening Service Sales Model
8.5.2 Sales Channel
8.5.3 Genetic Carrier Screening Service Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Clinical Labs
Eurofins Scientific
Fulgent Genetics
Gene by Gene
Illumina
Invitae
MedGenome Labs
My Baby Company
Myriad Genetics
Natera
NxGen MDx, LLC
OPKO Health
Thermo Fisher Scientific
Sonic Genetics

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂